Showing results 1 to 2 of 2
Title | Author(s) | Issue Date | |
---|---|---|---|
A phase 1b trial of AMG386 and temsirolimus in patients with advanced solid tumor Proceeding/Conference:26th EORTC-NCI-AACR Symposium | 2014 | ||
A phase I trial of ANG1/2-Tie2 inhibitor trebaninib (AMG386) and temsirolimus in advanced solid tumors (PJC008/NCI♯9041) Journal:Investigational New Drugs | 2016 |